Genetic Testing Market Outlook 2018

Print E-mail
PRNewsWire
Wednesday, 22 October 2014 17:40
Read more...
 

ASBM European Survey Presented to Italian Ministry of Health

Print E-mail
PRNewsWire
Wednesday, 22 October 2014 17:15
Read more...
 

MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics Overview, Cambridge Healthtech Advisors

Print E-mail
PRNewsWire
Wednesday, 22 October 2014 16:58
Read more...
 

Seed Coating Materials Market by Type (polymers, Colorants, Binders, and Other Additives), by Crop Type (Cereals Grains, Oilseeds, Fruits Vegetables) By Geography - Global Trends Forecasts to 2019

Print E-mail
PRNewsWire
Wednesday, 22 October 2014 16:26
Read more...
 

Connections Are Key For Independent Living Centers To Increase Employment Options For Californians With Disabilities

Print E-mail
PRNewsWire
Wednesday, 22 October 2014 16:00
Read more...
 

Harvoni® (ledipasvir/sofosbuvir) approved for the treatment of chronic hepatitis C, genotype 1 infection in adults; Diplomat to distribute

Print E-mail
PRNewsWire
Wednesday, 22 October 2014 15:53
Diplomat Specialty Pharmacy Facebook
Read more...
 

Hamilton Thorne Announces Private Placement Unit Offering of Up to CDN$750,000

Print E-mail
MarketWired
Wednesday, 22 October 2014 15:32

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR

Read more...
 

Lilly, Zymeworks Announce Expansion of Strategic Licensing and Collaboration Agreement

Print E-mail
PRNewsWire
Wednesday, 22 October 2014 15:15
Read more...
 

ZELTIQ to Present at Investor Conferences in November 2014

Print E-mail
MarketWired
Wednesday, 22 October 2014 15:05

SOURCE: ZELTIQ Aesthetics, Inc.

PLEASANTON, CA--(Marketwired - Oct 22, 2014) - ZELTIQ ®( NASDAQ : ZLTQ), a medical technology company focused on

Read more...
 

Sangamo BioSciences Reports Third Quarter 2014 Financial Results

Print E-mail
PRNewsWire
Wednesday, 22 October 2014 15:02
Sangamo BioSciences, Inc. Facebook
Read more...
 

Supreme Announces Financing

Print E-mail
MarketWired
Wednesday, 22 October 2014 14:59

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 22, 2014) -

NOT FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION

Read more...
 

Celmatix Presents Study at the ASRM Annual Meeting Showing That Most Fertility Patients Would Benefit From Moving More Rapidly to IVF Treatment

Print E-mail
MarketWired
Wednesday, 22 October 2014 14:45

NEW YORK, NY--(Marketwired - Oct 22, 2014) - Celmatix, a privately held personalized medicine company focused on maximizing lifelong fertility, today presented a study

Read more...
 

Xavier receives $19.6 million NIH award to enhance diversity in the biomedical workforce

Print E-mail
PRNewsWire
Wednesday, 22 October 2014 14:30
Read more...
 

Wissenschaftler aus Harvard entdecken positive Wirkung von probiotischer Hefe auf das kosystem des gesunden menschlichen Mikrobioms -- sogar bei Vorhandensein starker Antibiotoka

Print E-mail
MarketWired
Wednesday, 22 October 2014 13:40

22 oct. 2014 14h40 HE

VIENNA, AUSTRIA--(Marketwired - Oct 22, 2014) - Biocodex, ein französisches Pharma-Unternehmen in Familienbesitz, das sich auf die Bereitstellung von

Read more...
 

MediciNova Announces FDA Granted Orphan Drug Designation to MN-001 (tipelukast) for Idiopathic Pulmonary Fibrosis (IPF)

Print E-mail
GlobeNewswire
Wednesday, 22 October 2014 13:00

LA JOLLA, Calif.--MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), today announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to MN-001 (tipelukast) for treatment of idiopathic pulmonary fibrosis (IPF).

Read more...
 
<< Start < Prev 1 3 4 5 6 7 8 9 10 > End >>

Page 1 of 1953

Newsletter

BioMedReports Harvoni Approved For The Treatment Of Chronic Hepatitis C; TapImmune Provides Update on PolyStart™ Vaccine Pla... http://t.co/UoFNaJuTuD
9mreplyretweetfavorite
BioMedReports Active Stocks: Amgen, Alkermes, Nanosphere, Biogen Idec, Regulus Therapeutics: U.S. stocks turned lower in af... http://t.co/gHIHogcGHP
1hreplyretweetfavorite
BioMedReports Agios Pharma Reports Initiation of Phase 1/2 Clinical Trial of AG-221; Pluristem Advances its Second Major Cel... http://t.co/qkvJGEUaT5
navigation
Benzinga.com supporter Seeking Alpha Certified